LP15513-2

Creatine kinase.MB

Active

Description

Creatine kinase MB is the quantitation of the specific cardiac protein CKMB that is used in diagnosing myocardial infarction. Elevated values can be often be detected within 3-6 hours following the onset of chest pain. Testing should be performed at appropriate intervals because CKMB concentration peaks within 12-24 hours and generally returns to normal at 24-72 hours. Abnormal CKMB concentrations are often associated with ischemia or necrotic injury to the heart. Other conditions which may give elevated CK-MB values when the diagnosis of myocardial damage is unclear include skeletal muscle trauma, muscular dystrophy, dermatomyositis, Reyes syndrome, rhabdomyolysis, drug overdose, delirium tremens, chronic ethanol poisoning, and myopathic disorders. Source: Regenstrief Institute

Basic Part Properties

Part Name

Creatine kinase.MB

Part Display Name

Creatine kinase.MB

Part Type

Component (Describes the core component or analyte measured)

Created On

2000-05-04

Construct for LOINC Short Name

CK MB

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP15513-2

Language Variants Get Info

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.